Record #7622
The U.S. federal government may direct at least $2 trillion in financial benefits to pharmaceutical manufacturers over the next three years.
PendingRecorded occurrence
Each quote retains its own speaker, episode, publication date, timestamp when available, and full-source link.
Occurrence 1 of 1 · source record #7622 The Young Turks · Conservative Tax Revolt - December 31, 2025
Original quotemaybe even trillions to the big pharma.
Quote begins at 2:01:58
Exact speaking time unavailable; using the official episode publication date.
How the call settles
YES if official CMS, CBO, JCT, GAO, Treasury, or federal budget records identify at least $2 trillion in federal payments, reimbursements, tax expenditures, subsidies, grants, or direct purchases accruing to pharmaceutical manufacturers from January 1, 2026 through December 31, 2028; otherwise NO.
Our reasoning
Pending. It will be judged only by this stored rule: YES if official CMS, CBO, JCT, GAO, Treasury, or federal budget records identify at least $2 trillion in federal payments, reimbursements, tax expenditures, subsidies, grants, or direct purchases accruing to pharmaceutical manufacturers from January 1, 2026 through December 31, 2028; otherwise NO. Deadline or event: 2028-12-31.